ReviewJournal of inflammation research2026
Knowledge Mapping of Macrophages in Renal Fibrosis: A Bibliometric Analysis from 2014 to 2025.
Review in Journal of inflammation research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To conduct a comprehensive bibliometric analysis of global research trends on the role of macrophages in renal fibrosis from 2014 to 2025, identifying key contributors, thematic evolution, and emerging research frontiers. Methods: A total of 1,823 relevant publications were retrieved from the Web of Science Core Collection. Bibliometric analyses were performed using CiteSpace, VOSviewer, and Bibliometrix to examine publication outputs, country/institution contributions, journal influence, author productivity, co-citation networks, and keyword co-occurrence patterns. Results: Annual publications showed a consistent upward trend, with China being the most productive country (accounting for 33.45% of the overall publications), followed by the United States. Monash University and The Chinese University of Hong Kong have the highest number of citations per article. Conclusion: This study provides a comprehensive mapping of the research landscape on macrophages in renal fibrosis, demonstrating a clear shift from mechanistic studies toward translational research focusing on macrophage polarization and diagnostic applications. The findings highlight China's dominant contribution and underscore emerging priorities that may guide future therapeutic innovation in renal fibrosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.